Selank Mechanism of Action
How a peptide engineered to stabilize an immune signal ended up with unexpected effects on neurotrophic and monoamine pathways relevant to anxiolytic research.
Built on a Stabilized Immune Peptide
Selank is a heptapeptide built by appending a stabilizing tripeptide (proline-glycine-proline) onto the C-terminus of tuftsin, an immunomodulatory peptide that enhances macrophage and neutrophil activity but breaks down in the bloodstream within seconds in its native form. The stabilization retained tuftsin's original immune-enhancing activity while extending its functional half-life enough to study.
An Unexpected Second Mechanism: Neurotrophic and Monoamine Effects
What the researchers didn't anticipate was a second, unrelated property: Selank research models show effects on brain-derived neurotrophic factor (BDNF) expression and on the turnover of monoamine neurotransmitters (including serotonin and dopamine), alongside effects on GABAergic signaling. These effects are proposed to be the basis for Selank's anxiolytic-like research profile — distinct from, and apparently unrelated to, the tuftsin-derived immune activity that was the original design target.
A Proposed Alternative to Classical Anxiolytics
Selank's research interest partly stems from what it doesn't appear to do: unlike benzodiazepine-class anxiolytics, research models have not shown the sedation or dependence liability typically associated with GABA-A receptor-targeting drugs, which has motivated research into whether Selank's BDNF/monoamine-based mechanism represents a mechanistically distinct approach to anxiolytic research.
How This Differs From Semax
Semax reaches a similar neurotrophic research territory (also elevating BDNF) from a completely different starting point — a stabilized fragment of ACTH rather than a stabilized fragment of tuftsin. Despite the different lineages, both were stabilized using the same Pro-Gly-Pro technique by overlapping Moscow research teams. See our full Semax vs Selank comparison for more detail.
- BDNF expression and neurotrophic mechanism research
- Monoamine neurotransmitter turnover studies
- Anxiolytic-like effects research without benzodiazepine-class mechanisms
- Comparative mechanism research vs Semax
Selank mechanism questions
Is Selank's anxiolytic research related to its immune (tuftsin) origin?
No — the anxiolytic-like effects appear to come from an unrelated, unexpected mechanism involving BDNF expression and monoamine neurotransmitter turnover, distinct from the immunomodulatory tuftsin activity Selank was originally engineered to stabilize.
How does Selank's mechanism compare to Semax's?
Both elevate BDNF and were stabilized using the same Pro-Gly-Pro technique by overlapping Moscow research teams, but they start from completely different parent molecules: Selank from the immune peptide tuftsin, and Semax from a fragment of ACTH.
Interested in Selank?
See pricing and order on the product page, or browse our other cognitive and nootropic peptides.